Specificity of antibodies directed against the cytolethal distending toxin of Haemophilus ducreyi in patients with chancroid

Microbial Pathogenesis

Volumn 35, Issue 3, 2003, Pages 133-137

  Mbwana, Judica ^a,b   Ahmed, Hinda J ^b   Ahlman, Karin ^b   Sundaeus, Vivian ^b   Dahlén, Gunnar ^c   Lyamuya, Eligius ^a   Lagergård, Teresa ^b  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b Box 435 ^*  (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Chancroid; Cytolethal distending toxin; Haemophilus ducreyi; Neutralizing antibodies

Indexed keywords

BACTERIAL TOXIN; CYTOLETHAL DISTENDING TOXIN; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BACTERIUM CULTURE; BLOOD DONOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DRUG ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HAEMOPHILUS DUCREYI; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PERIODONTITIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SWEDEN; TANZANIA; ULCUS MOLLE;

HAEMOPHILUS; HAEMOPHILUS DUCREYI;

EID: 0042121339     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0882-4010(03)00111-6     Document Type: Article

References (21)

1. Trees D.L., Morse S.A. Chancroid and Haemophilus ducreyi: an update. Clin Microbiol Rev. 8:1995;357-375.
2. Jessamine P.G., Ronald A.R. Chancroid and the role of genital ulcer disease in the spread of human retroviruses. Med Clin North Am. 74:1990;1417-1431.
3. Campagnari A.A., Wild L.M., Griffiths G.E., Karalus R.J., Wirth M.A., Spinola S.M. Role of lipooligosaccharides in experimental dermal lesions caused by Haemophilus ducreyi. Infect Immun. 59:1991;2601-2608.
4. Castellazzo A., Shero M., Apicella M.A., Spinola S.M. Expression of pili by Haemophilus ducreyi. J Infect Dis. 165:(Suppl 1):1992;S198-S199.
5. San Mateo L.R., Hobbs M.M., Kawula T.H. Periplasmic copper-zinc superoxide dismutase protects Haemophilus ducreyi from exogenous superoxide. Mol Microbiol. 27:1998;391-404.
6. Bong C.T., Throm R.E., Fortney K.R., Katz B.P., Hood A.F., Elkins C., Spinola S.M. DsrA-deficient mutant of Haemophilus ducreyi is impaired in its ability to infect human volunteers. Infect Immun. 69:2001;1488-1491.
7. Totten P.A., Norn D.V., Stamm W.E. Characterization of the hemolytic activity of Haemophilus ducreyi. Infect Immun. 63:1995;4409-4416.
8. Cope L.D., Lumbley S., Latimer J.L., Klesney-Tait J., Stevens M.K., Johnson L.S., Purven M., Munson R.S., Lagergard T., Radolf J.D., Hansen E.J. A diffusible cytotoxin of Haemophilus ducreyi. Proc Natl Acad Sci USA. 94:1997;4056-4061.
9. Pickett C.L., Whitehouse C.A. The cytolethal distending toxin family. Trends Microbiol. 7:1999;292-297.
10. Cortez-Bratti X., Chaves-Olarte E., Lagergård T., Thelestam M. A cytotoxin from chancroid bacterium Haemophilus ducreyi induces cycle arrest in the G2 phase. J Clin Invest. 103:1999;107-115.
11. Shenker B.J., McKay T., Datar S., Miller M., Chowhan R., Demuth D. Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells. J Immunol. 162:1999;4773-4780.
12. Frisk A., Lebens M., Johansson C., Ahmed H., Svensson L., Ahlman K., Lagergard T. The role of different protein components from the Haemophilus ducreyi cytolethal-distending toxin in the generation of cell toxicity. Microb Pathog. 30:2001;313-313.
13. Ahmed H.J., Svensson L.A., Cope L.D., Latimer J.L., Hansen E.J., Ahlman K., Bayat-Turk J., Klamer D., Lagergard T. Prevalence of cdtABC genes encoding cytolethal-distending toxin among Haemophilus ducreyi and Actinobacillus actinomycetemcomitans strains. J Med Microbiol. 50:2001;860-864.
14. Yamato R., Ohara M., Nishikubo S., Fujiwara T., Kawamoto T., Ueno Y., Komatsuzawa H., Okuda K., Kurihara H., Suginaka H., Oswald E., Tanne K., Sugai M. Prevalence of cytolethal distending toxin production among periodontopathogenic bacteria. J Clin Microbiol. 41:2003;1391-1398.
15. Bang D.D., Nielsen E.M., Scheutz F., Pedersen K., Handberg K., Madsen M. PCR detection pf seven virulence and toxin genes of Campylobacter jejuni and Campylobacter coli isolates from Danish pigs and cattle and cytolethal distending toxin production of the isolates. J Appl Microbiol. 94:2003;1003-1014.
16. Purven M., Frisk A., Lonnroth I., Lagergard T. Purification and identification of Haemophilus ducreyi cytotoxin by use of a neutralizing monoclonal antibody. Infect Immun. 65:1997;3496-3499.
17. Lagergard T., Purven M. Neutralizing antibodies to Haemophilus ducreyi cytotoxin. Infect Immun. 61:1993;1589-1592.
18. Wising C.L., Svensson L., Ahmed H., Sundaeus V., Ahlman K., Jonsson I.-M., Molne L., Lagergard T. Toxicity and immunogenicity of purified Haemophilus ducreyi cytolethal distending toxin in a rabbit model. Microb Pathog. 33:2002;49-62.
19. Ahmed H.J., Mbwana J., Gunnarsson E., Ahlman K., Guerino C., Svensson L.A., Mhalu F., Lagergard T. Etiology of genital ulcer diseases and association with human immunodeficiency virus infection in two Tanzania cities. Sex Transm Dis. 30:2003;114-119.
20. Meade B., Deforest A., Edwards K., Romani T., ynn F., O'Brien C., Swartz C., Reed G., Deloria M. Description and evaluation of serologic assays employed in multicenter trial of acellular pertussis vaccines. Pediatrics. 96:1995;570-575.
21. Isacson J., Trollfors B., Lagergard T., Taranger J. Comparison of a toxin neutralizing assay and ELISA for determination of pertusis toxin antibodies. Serodiagnosis Immunother. 8:1997;163-167.